◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.AcnePublished: June 5, 2026
Isotretinoin Dosing for Acne Varies Widely Among Dermatologists
Researchers studied how dermatologists prescribe isotretinoin for acne and found that dosing varies widely. They looked at data from over 9,500 patients and found that some patients received higher or lower doses than others. The study suggests that there may be room for improvement in prescribing practices.
Why it matters: Understanding isotretinoin dosing variability may help improve acne treatment and ensure equitable care for patients.
This study was a retrospective cohort study, which means it looked back at existing data rather than conducting a new experiment. The study only included patients from Kaiser Permanente Northern California, which may limit its generalizability to other populations.
Small Human StudySmall or uncontrolled human study. Results are preliminary.AcnePublished: June 1, 2026
Combination Treatment May Help Reduce Acne Symptoms
A small study looked at the combination of clascoterone cream and adapalene gel to treat acne. Researchers found that this combination may help reduce acne symptoms, including inflammation and lesion counts, and improve quality of life for patients. However, more research is needed to confirm these findings.
Why it matters: Understanding effective treatments for acne can help individuals manage their symptoms and improve their skin health.
This was a small, open-label pilot study with a short duration (16 weeks) and a small sample size (20 patients).
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.WrinklesPublished: June 1, 2026
Understanding Photoaging and Its Treatments
Researchers studied photoaging, a type of skin aging caused by sun exposure, and its effects on skin appearance. They found that chronic sun exposure can lead to wrinkles and pigment changes. The study also looked at how different treatments can help improve photoaged skin.
Why it matters: Understanding photoaging and its treatments may help people take steps to prevent or reduce its effects on their skin.
This review is based on existing research and does not present new findings. The effectiveness of treatments for photoaging may vary depending on individual skin types and conditions.
In VitroCell or tissue culture experiments. No human or animal data.Skin Barrier DamagePublished: May 21, 2026
Konjac Ceramide May Help Reduce Itch in Skin Conditions
Researchers studied how konjac ceramide affects the expression of a protein called semaphorin 3A in human skin cells. They found that konjac ceramide may increase the production of this protein, which could help reduce itch in skin conditions like atopic dermatitis. However, more research is needed to confirm these findings.
Why it matters: This study may help us better understand how to reduce itch in skin conditions, which can be a major issue for people with conditions like atopic dermatitis.
This study was conducted in a lab using human skin cells, so its findings may not directly translate to real-world skin conditions. More research is needed to confirm these results and understand their relevance to human skin health.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.AcnePublished: May 20, 2026
Isotretinoin Treatment in Adolescence May Not Affect Adult Height
Researchers studied whether taking isotretinoin for acne during adolescence affects adult height. They analyzed data from over 379,000 individuals in Denmark and found that isotretinoin use was not associated with reduced adult height. However, the study had limitations and more research is needed to confirm these findings.
Why it matters: This study may help inform decisions about isotretinoin treatment for acne in adolescents.
This study was a cross-sectional analysis of existing data and did not directly measure the effects of isotretinoin on growth. The sample size was large, but the study's design and limitations should be considered when interpreting the results.
In VitroCell or tissue culture experiments. No human or animal data.Published: May 12, 2026
Niosomal Cream May Help Improve Tretinoin Stability and Efficacy
Researchers developed a new cream that encapsulates tretinoin, a common skincare ingredient, in tiny particles called niosomes. They tested this cream in lab experiments and found that it may improve tretinoin's stability and effectiveness. However, more research is needed to confirm these results.
Why it matters: This study may help improve our understanding of how to deliver tretinoin more effectively in skincare products.
Lab experiments only, more in vivo and clinical research is needed to validate these results.
Small Human StudySmall or uncontrolled human study. Results are preliminary.AcnePublished: May 1, 2026
Topical Gel May Help Treat Rare Skin Condition
Researchers studied a 15-year-old boy with a rare skin condition called confluent and reticulated papillomatosis (CARP). He didn't respond to initial treatments, but using a specific topical gel and body wash led to complete clearance after 3 months. This suggests that the gel may be a safe and effective alternative for treating CARP.
Why it matters: This study highlights the potential for non-systemic treatments for CARP, a condition often treated with oral or topical antibiotics.
This case study involved a single patient and a short treatment duration. Further research is needed to confirm these findings.
Small Human StudySmall or uncontrolled human study. Results are preliminary.AcnePublished: April 30, 2026
Is routine blood monitoring necessary for acne patients on isotretinoin?
Researchers studied whether routine blood monitoring is needed for patients with acne who take isotretinoin, a common treatment for severe acne. They looked at records from 89 patients and found that only a few had abnormal blood results that led to changes in their treatment. However, it's unclear if this applies to all patients, especially those with other health conditions.
Why it matters: Understanding the need for blood monitoring could help doctors provide better care for patients with acne and reduce unnecessary testing.
This study was small and retrospective, and more research is needed to confirm these findings. The study only looked at patients from one hospital in South Africa, which may not be representative of all patients with acne.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.AcnePublished: April 1, 2026
New Acne Treatments Beyond Isotretinoin Show Promise
Researchers reviewed emerging systemic therapies for moderate-to-severe acne, finding some promising alternatives to isotretinoin. These treatments include antibiotics, hormonal agents, and biologic therapies, which may help improve acne symptoms. However, more studies are needed to compare their effectiveness to isotretinoin.
Why it matters: Understanding these new treatments may lead to better acne management options for people with moderate-to-severe acne.
Most treatments lack head-to-head comparisons with isotretinoin, and further large-scale comparative studies are needed to define their roles within evidence-based acne management algorithms.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.AcnePublished: March 31, 2026
Expert Consensus on Isotretinoin Use for Severe Acne
Researchers developed a consensus on the use of isotretinoin for severe acne, recommending it for adults and adolescents with certain types of acne. The consensus also suggested early initiation and tailored dosing. However, there is still some uncertainty around the optimal dosing and monitoring.
Why it matters: This study may help guide dermatologists in treating severe acne, but its findings should be interpreted with caution.
The consensus was developed through a modified Delphi process and literature review, but some areas of agreement, such as cumulative dosing, laboratory testing frequency, and duration of posttreatment washout, were not universally agreed upon.
Small Human StudySmall or uncontrolled human study. Results are preliminary.Redness / Facial RednessPublished: March 31, 2026
Generalized Keratosis Pilaris Rubra: A Rare Skin Condition
Researchers studied a rare skin condition called generalized keratosis pilaris rubra, which causes red bumps and inflammation. A single case was reported, where a 19-year-old man had widespread symptoms. The study found that the condition can be difficult to diagnose due to similarities with another skin condition.
Why it matters: Understanding this condition may help dermatologists diagnose and treat similar cases more accurately.
This study is a single case report, and the findings may not be representative of all cases of generalized keratosis pilaris rubra.
Small Human StudySmall or uncontrolled human study. Results are preliminary.AcnePublished: March 26, 2026
Isotretinoin Use in Pediatric Patients: Barriers to Access and Treatment Continuity
Researchers studied how pediatric patients with severe acne access and use isotretinoin, a treatment for acne. They found that many patients faced difficulties with scheduling, pharmacies, and financial issues, which may have led to gaps in treatment. Despite these challenges, most patients felt their treatment was successful.
Why it matters: This study highlights potential barriers to effective acne treatment in underserved populations, which may inform strategies to improve access to care.
This study had a small sample size of 42 pediatric patients and was conducted at a single urban safety-net hospital.